TOP HEADLINES

Featured Story

  • $4B VC shop lays out its vision for the future of digital health

    Anyone with a passing interest in tech startups is unlikely to be shocked by Silicon Valley VC Andreessen Horowitz listing digital health as one of its top 16 trends. But as one of the organizations with some power over how these trends play out, the reasoning behind Andreessen Horowitz's list makes for interesting reading.

Biogen taps Google's data analytics skills for MS research

The Google X lab that spawned smart contact lenses and self-driving cars is teaming up with Biogen Idec to unravel patient-to-patient variation in the progression of multiple sclerosis.

AstraZeneca strikes deal with Box as IT revamp continues

Box has added a big-name client just days after pulling off a $175 million IPO. The deal sees AstraZeneca join Allergan and Eli Lilly on the list of major biopharma companies that use Box's cloud content sharing and collaboration tools.

EMA posts guide to help IT teams with its new pharmacovigilance database

The European Medicines Agency (EMA) has taken another step toward the creation of a database of all suspected adverse reactions reported within its jurisdiction. The EMA laid out the technical details of the system and how it will affect biopharma companies in a 100-page guide it published this week.

Analyst: FDA guidance will slow near-term adoption of wearables

Juniper Research analyst James Moar told Outsourcing-Pharma the placing of limits on the types of information that can have medical uses will slow uptake.

GoBalto eyes Asian expansion after $12M Mitsui-led financing

Study startup specialist goBalto is preparing to up its game in Asia. The San Francisco, CA-based software developer outlined the strategy after raising $12 million from new backers, including Japan's Mitsui Global Investment.

MORE NEWS

From Our Sister Sites

FierceBiotech

In another sign last year's bull market for biopharma has survived into 2015, Flex Pharma, at work on a biotech dietary supplement, priced an $86.4 million IPO above its expected range.

FierceMedicalDevices

Royal Philips and Teva Pharmaceutical Industries kicked off operations for the companies' new med tech incubator in Israel, reaffirming their commitment to R&D at a transitional moment.